Today, the screeners at HealthTechMovers.com picked up 5 HealthTech Stocks up over 41% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
WallStreetMovers.com is also looking into these tickers BMRN, PEPG, BLCO, COO, SAGE.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Kintara Therapeutics, KTRA
Summary: Kintara Therapeutics Inc. is a biopharmaceutical company. It is focused on the development of new solid tumor cancer therapies. The company's program includes VAL-083 for GBM and REM-001 for cutaneous metastatic breast cancer, which are in clinical stage. Kintara Therapeutics Inc. is based in San Diego, California.
Recent KTRA Stock Price (approx 10:00am EST.): $7.17
Previous Close for KTRA Stock: $6.7
Percentage Price Change Past 10 Days for KTRA stock: +72%
TipRanks.com reports that Kintara Therapeutics stock currently has a Hold rating for KTRA stock.
Click here to get the full story on KTRA stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: NeuroOne Medical Technologies Corporation is a medical technology company. It focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne Medical Technologies Corporation is based in EDEN PRAIRIE, Minn.
Recent NMTC Stock Price (approx 10:00am EST.): $1.57
Previous Close for NMTC Stock: $1.41
Percentage Price Change Past 10 Days for NMTC stock: +64%
TipRanks.com reports that NeuroOne Medical Technologies stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for NMTC stock with an average price target is $3.25.
Click here to get the full story on NMTC stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas.
Recent VAXX Stock Price (approx 10:00am EST.): $3.05
Previous Close for VAXX Stock: $2.62
Percentage Price Change Past 10 Days for VAXX stock: +61%
Click here to get the full story on VAXX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON.
Recent NUTX Stock Price (approx 10:00am EST.): $1.82
Previous Close for NUTX Stock: n/a
Percentage Price Change Past 10 Days for NUTX stock: +53%
Click here to get the full story on NUTX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Recent ARDX Stock Price (approx 10:00am EST.): $1.80
Previous Close for ARDX Stock: $1.72
Percentage Price Change Past 10 Days for ARDX stock: +41%
TipRanks.com reports that Ardelyx stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for ARDX stock with an average price target is $6.53.
Click here to get the full story on ARDX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
WallStreetMovers.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to WallStreetMovers.com.
